Back
First Trust NASDAQ Technology Dividend Index Fund Vs. Akero Therapeutics Industry Stock Comparison
Buy
57
TDIV
First Trust NASDAQ Technology Dividend Index Fund
Last Price:
$91.63
Seasonality Move:
0.9%
Sell
39
AKRO
Akero Therapeutics
Last Price:
$51.76
Seasonality Move:
45.38%
Buy
57
First Trust NASDAQ Technology Dividend Index Fund (TDIV)
is a Buy
Is First Trust NASDAQ Technology Dividend Index Fund a Buy, Sell or Hold?
-
The current First Trust NASDAQ Technology Dividend Index Fund [TDIV] share price is $91.52. The Score for TDIV is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
TDIV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $51.76. The Score for AKRO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TDIV Stock Price Chart
What is First Trust NASDAQ Technology Dividend Index Fund's stock price today?
-
The First Trust NASDAQ Technology Dividend Index Fund share price today is $91.52Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TDIV is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $51.76The current trend is moderately bearish and AKRO is experiencing slight selling pressure.
TDIV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 24.12 | Buy |
Relative Strength Index (14 RSI): | 70.01 | Buy |
Chaikin Money Flow: | -54886 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.51 - 91.49) | Buy |
Bollinger Bands (100): | (72.5 - 86.6) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.3 | Buy |
Relative Strength Index (14 RSI): | 49.62 | Sell |
Chaikin Money Flow: | -246824 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.73 - 55.19) | Sell |
Bollinger Bands (100): | (40.15 - 52.07) | Buy |
TDIV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 91.8 | Sell |
20-day SMA: | 89.79 | Buy |
50-day SMA: | 84.68 | Buy |
200-day SMA: | 79.92 | Buy |
8-day EMA: | 71.38 | Buy |
20-day EMA: | 41.42 | Buy |
50-day EMA: | 19.58 | Buy |
200-day EMA: | 5.34 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.61 | Buy |
20-day SMA: | 53.26 | Sell |
50-day SMA: | 49.47 | Buy |
200-day SMA: | 39.46 | Buy |
8-day EMA: | 52.01 | Sell |
20-day EMA: | 52.24 | Sell |
50-day EMA: | 49.97 | Buy |
200-day EMA: | 41.21 | Buy |
First Trust NASDAQ Technology Dividend Index Fund Earnings Growth & TDIV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
First Trust NASDAQ Technology Dividend Index Fund Technical Analysis
Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |